LeeSRosenMD
Hematology • Santa Monica, CAMyeloproliferative Disorder Hematology-Oncology
Professor, Medicine, University of California Los Angeles David Geffen SOM
Dr. Rosen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2020 Santa Monica Blvd
Ste 510
Santa Monica, CA 90404Phone+1 310-633-8400Fax+1 310-633-8419
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1993 - 1996- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1990 - 1993
Baylor College of MedicineClass of 1990
Certifications & Licensure
CA State Medical License 1991 - 2025- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow (FACP) American College of Physicians, 2011
- Super Doctor SuperDoctors.com
Clinical Trials
- Tocladesine in Treating Patients With Recurrent or Progressive Metastatic Colorectal Cancer Start of enrollment: 2001 Apr 01
- Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2000 Dec 01
- Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors Start of enrollment: 2001 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 33 citationsEfficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase Fusion-Positive Lung Cancers.Alexander Drilon, Daniel S W Tan, Ulrik N Lassen, Serge Leyvraz, Yongmei Liu
JCO Precision Oncology. 2022-01-01 - 118 citationsComparison of the pharmacokinetics and pharmacodynamics of S-1 between Caucasian and East Asian patients.Benjamin Chuah, Boon Cher Goh, Soo-Chin Lee, Richie Soong, Fayce Lau
Cancer Science. 2011-02-01 - 187 citationsPhase I Study Evaluating WEE1 Inhibitor AZD1775 As Monotherapy and in Combination With Gemcitabine, Cisplatin, or Carboplatin in Patients With Advanced Solid Tumors.Suzanne Leijen, Robin M.J.M. van Geel, Anna C. Pavlick, Raoul Tibes, Lee S. Rosen
Journal of Clinical Oncology. 2016-10-31
Professional Memberships
- Fellow
- Member
- Member
- Member
Other Languages
- Hebrew, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
